Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Olanzapine on Central Insulin Action in Healthy Volunteers
NCT03741478Phase 1Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Oct 2019
- Primary completion
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of olanzapine and insulin lispro (2 arms), sponsored by Center for Addiction and Mental Health. Primary endpoint: Endogenous Glucose Production. Started Oct 2019; status: completed.
02
Drugs
olanzapineinsulin lispro
Beyond the preview
Go deeper on NCT03741478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03741478.